Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Medical Case Reports Journal|June 28, 2017
Optic perineuritis: a retrospective case seriesOlle Bergman, Tommy Andersson, Madeleine Zetterberg
The International Journal of Neuropsychopharmacology|April 7, 2011
Study on the possible association of brain-derived neurotrophic factor polymorphism with the developmental course of symptoms of attention deficit and hyperactivityOlle Bergman, Lars Westberg, Paul Lichtenstein, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 24, 2010
Preliminary evidence that polymorphisms in dopamine-related transcription factors LMX1A, LMX1B and PITX3 are associated with schizophreniaOlle Bergman, Lars Westberg, Lars-Göran Nilsson, et al.
Parkinsonism & Related Disorders|February 9, 2007
S18Y in ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) associated with decreased risk of Parkinson's disease in SwedenAndrea Carmine Belin, Marie Westerlund, Olle Bergman, et al.
Neuropsychologia|March 26, 2011
Preliminary evidence that allelic variation in the LMX1A gene influences training-related working memory improvementMartin Bellander, Yvonne Brehmer, Helena Westerberg, et al.
Frontiers in Aging Neuroscience|July 1, 2010
Age-Related Olfactory Decline is Associated with the BDNF Val66met Polymorphism: Evidence from a Population-Based StudyMargareta Hedner, Lars-Göran Nilsson, Jonas K Olofsson, et al.
Neurobiology of Aging|April 19, 2008
PITX3 polymorphism is associated with early onset Parkinson's diseaseOlle Bergman, Anna Håkansson, Lars Westberg, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 16, 2006
Cyclooxygenase-2 polymorphisms in Parkinson's diseaseAnna Håkansson, Olle Bergman, Cecilia Chrapkowska, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 4, 2009
Do polymorphisms in transcription factors LMX1A and LMX1B influence the risk for Parkinson's disease?Olle Bergman, Anna Håkansson, Lars Westberg, et al.
Pageof 1